Vanguard Group Inc Chroma Dex Corp. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CDXC
# of Institutions
87Shares Held
16.5MCall Options Held
91.7KPut Options Held
18.9K-
Black Rock Inc. New York, NY3.12MShares$18.3 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.97MShares$17.4 Million4.5% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.6 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA1.13MShares$6.63 Million0.0% of portfolio
-
State Street Corp Boston, MA555KShares$3.25 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $401M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...